Skip to main content
. 2016 May 9;7(24):36971–36987. doi: 10.18632/oncotarget.9235

Figure 4. Proteasome negative regulation of cleaved-Par-4.

Figure 4

A-B. Cl-Par-4 cancer cells were treated with either 10μM MG-132 for 2h or 2μM MG-132 for 24h. C. Schematic of cl-Par-4 transgene and the predicted ubiquitination sites from bioinformatic analysis.